122 related articles for article (PubMed ID: 35658529)
41. Neutralizing Antibodies Targeting HIV-1 gp41.
Caillat C; Guilligay D; Sulbaran G; Weissenhorn W
Viruses; 2020 Oct; 12(11):. PubMed ID: 33114242
[TBL] [Abstract][Full Text] [Related]
42. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
[TBL] [Abstract][Full Text] [Related]
43. Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
Ye L; Wen Z; Dong K; Wang X; Bu Z; Zhang H; Compans RW; Yang C
PLoS One; 2011; 6(5):e14813. PubMed ID: 21625584
[TBL] [Abstract][Full Text] [Related]
44. Stabilizing the native trimer of HIV-1 Env by destabilizing the heterodimeric interface of the gp41 postfusion six-helix bundle.
Kesavardhana S; Varadarajan R
J Virol; 2014 Sep; 88(17):9590-604. PubMed ID: 24920800
[TBL] [Abstract][Full Text] [Related]
45. A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.
Lai RP; Hock M; Radzimanowski J; Tonks P; Hulsik DL; Effantin G; Seilly DJ; Dreja H; Kliche A; Wagner R; Barnett SW; Tumba N; Morris L; LaBranche CC; Montefiori DC; Seaman MS; Heeney JL; Weissenhorn W
J Biol Chem; 2014 Oct; 289(43):29912-26. PubMed ID: 25160627
[TBL] [Abstract][Full Text] [Related]
46. Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail.
Durham ND; Yewdall AW; Chen P; Lee R; Zony C; Robinson JE; Chen BK
J Virol; 2012 Jul; 86(14):7484-95. PubMed ID: 22553332
[TBL] [Abstract][Full Text] [Related]
47. SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers.
Ringe RP; Colin P; Torres JL; Yasmeen A; Lee WH; Cupo A; Ward AB; Klasse PJ; Moore JP
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619555
[TBL] [Abstract][Full Text] [Related]
48. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
[TBL] [Abstract][Full Text] [Related]
49. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
50. Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.
Park EJ; Vujcic LK; Anand R; Theodore TS; Quinnan GV
J Virol; 1998 Sep; 72(9):7099-107. PubMed ID: 9696803
[TBL] [Abstract][Full Text] [Related]
51. Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.
Dieltjens T; Heyndrickx L; Willems B; Gray E; Van Nieuwenhove L; Grupping K; Vanham G; Janssens W
Retrovirology; 2009 Dec; 6():113. PubMed ID: 20003438
[TBL] [Abstract][Full Text] [Related]
52. Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities.
Alsmadi O; Tilley SA
J Virol; 1998 Jan; 72(1):286-93. PubMed ID: 9420226
[TBL] [Abstract][Full Text] [Related]
53. A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.
Crooks ET; Moore PL; Franti M; Cayanan CS; Zhu P; Jiang P; de Vries RP; Wiley C; Zharkikh I; Schülke N; Roux KH; Montefiori DC; Burton DR; Binley JM
Virology; 2007 Sep; 366(2):245-62. PubMed ID: 17580087
[TBL] [Abstract][Full Text] [Related]
54. Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells.
Richard J; Nguyen DN; Tolbert WD; Gasser R; Ding S; Vézina D; Yu Gong S; Prévost J; Gendron-Lepage G; Medjahed H; Gottumukkala S; Finzi A; Pazgier M
mBio; 2021 Oct; 12(5):e0140521. PubMed ID: 34579568
[TBL] [Abstract][Full Text] [Related]
55. Alternative substitutions of N332 in HIV-1
Jeffy J; Parthasarathy D; Ahmed S; Cervera-Benet H; Xiong U; Harris M; Mazurov D; Pickthorn S; Herschhorn A
mBio; 2024 Apr; 15(4):e0268623. PubMed ID: 38470051
[TBL] [Abstract][Full Text] [Related]
56. Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma.
Davis KL; Bibollet-Ruche F; Li H; Decker JM; Kutsch O; Morris L; Salomon A; Pinter A; Hoxie JA; Hahn BH; Kwong PD; Shaw GM
J Virol; 2009 Feb; 83(3):1240-59. PubMed ID: 19019969
[TBL] [Abstract][Full Text] [Related]
57. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.
Qualls ZM; Choudhary A; Honnen W; Prattipati R; Robinson JE; Pinter A
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237828
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles.
Nguyen HT; Wang Q; Anang S; Sodroski JG
J Virol; 2023 Mar; 97(3):e0185722. PubMed ID: 36815832
[TBL] [Abstract][Full Text] [Related]
59. Association of enhanced HIV-1 neutralization by a single Y681H substitution in gp41 with increased gp120-CD4 interaction and macrophage infectivity.
Ringe R; Bhattacharya J
PLoS One; 2012; 7(5):e37157. PubMed ID: 22606344
[TBL] [Abstract][Full Text] [Related]
60. Immunization with hybrid proteins containing the membrane proximal external region of HIV-1.
Strasz N; Morozov VA; Kreutzberger J; Keller M; Eschricht M; Denner J
AIDS Res Hum Retroviruses; 2014 May; 30(5):498-508. PubMed ID: 24392780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
